UFP Technologies, Inc. (NASDAQ:UFPT – Get Free Report) Director Daniel C. Croteau sold 6,846 shares of the company’s stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $228.41, for a total value of $1,563,694.86. Following the completion of the sale, the director now owns 1,785 shares of the company’s stock, valued at approximately $407,711.85. The trade was a 79.32 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
UFP Technologies Stock Down 5.4 %
UFP Technologies stock opened at $215.24 on Tuesday. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.57 and a quick ratio of 1.43. UFP Technologies, Inc. has a 1-year low of $188.50 and a 1-year high of $366.41. The stock has a market cap of $1.65 billion, a PE ratio of 30.70 and a beta of 1.04. The stock’s fifty day moving average is $256.34 and its two-hundred day moving average is $288.96.
UFP Technologies (NASDAQ:UFPT – Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The industrial products company reported $2.46 EPS for the quarter, beating analysts’ consensus estimates of $2.01 by $0.45. The company had revenue of $144.07 million for the quarter, compared to analyst estimates of $141.67 million. UFP Technologies had a net margin of 11.74% and a return on equity of 18.92%.
Institutional Trading of UFP Technologies
Analyst Ratings Changes
Separately, StockNews.com cut UFP Technologies from a “hold” rating to a “sell” rating in a report on Thursday, January 23rd.
Read Our Latest Research Report on UFP Technologies
About UFP Technologies
UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.
Further Reading
- Five stocks we like better than UFP Technologies
- Bank Stocks – Best Bank Stocks to Invest In
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Overbought Stocks Explained: Should You Trade Them?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What is the Australian Securities Exchange (ASX)
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for UFP Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UFP Technologies and related companies with MarketBeat.com's FREE daily email newsletter.